Anil Namboodiripad
Corporate Officer/Principal bij DR. REDDY'S LABORATORIES LIMITED
Profiel
Anil Namboodiripad is currently the Chief Executive Officer at SCRIPT Biosciences, Inc. since 2021.
He is also the Global Head-Proprietary Products at Dr. Reddy's Laboratories Ltd.
since 2016.
Dr. Namboodiripad holds a doctorate degree from The University of Texas at Austin.
Actieve functies van Anil Namboodiripad
| Bedrijven | Functie | Begin |
|---|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Corporate Officer/Principal | 01-12-2016 |
Script Biosciences, Inc.
 Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Chief Executive Officer | 01-01-2021 |
Opleiding van Anil Namboodiripad
| The University of Texas at Austin | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DR. REDDY'S LABORATORIES LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Script Biosciences, Inc.
Script Biosciences, Inc. Packaged SoftwareTechnology Services SCRIPT Biosciences, Inc. develops a genome editing platform. The American company was founded in 2020. Anil Namboodiripad has been the CEO of the company since 2021. | Technology Services |
